Comment on “Refracture risk and all-cause mortality after vertebral fragility fractures: Anti-osteoporotic medications matter”

• Peng Qu,
• Hongyan Hao,
• Xueliang Zhang

Affiliations

Peng Qu

Department of Orthopedics, The First Hospital of Lanzhou University, Lanzhou City 730000, Gansu, China

Hongyan Hao

Department of Orthopedics, The First Hospital of Lanzhou University, Lanzhou City 730000, Gansu, China

Xueliang Zhang

Corresponding author.; Department of Orthopedics, The First Hospital of Lanzhou University, Lanzhou City 730000, Gansu, China